Advent International’s Rapid Micro Biosystems RPID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Sell
552,377
-25,400
-4% -$93K 0.03% 27
2025
Q4
$1.68M Hold
577,777
0.03% 23
2025
Q3
$1.93M Hold
577,777
0.04% 25
2025
Q2
$1.99M Hold
577,777
0.06% 21
2025
Q1
$1.53M Hold
577,777
0.05% 22
2024
Q4
$520K Hold
577,777
0.01% 23
2024
Q3
$514K Hold
577,777
0.01% 22
2024
Q2
$381K Hold
577,777
0.01% 23
2024
Q1
$560K Hold
577,777
0.01% 19
2023
Q4
$428K Hold
577,777
0.01% 20
2023
Q3
$624K Hold
577,777
0.01% 19
2023
Q2
$578K Hold
577,777
0.01% 20
2023
Q1
$757K Hold
577,777
0.01% 24
2022
Q4
$653K Hold
577,777
0.01% 24
2022
Q3
$1.87M Hold
577,777
0.02% 23
2022
Q2
$2.48M Hold
577,777
0.02% 22
2022
Q1
$3.92M Hold
577,777
0.02% 22
2021
Q4
$6.15M Sell
577,777
-1
-0% -$16 0.03% 22
2021
Q3
$10.7M Buy
+577,778
New +$11.9M 0.05% 21

Other funds holding RPID

Advent International's RPID Position: Q1 2026 in Review

Advent International reduced its Rapid Micro Biosystems (RPID) stake by 4.4% in Q1 2026, selling an estimated $93K and leaving 552,377 shares worth $1.25M. The position accounts for 0.03% of the portfolio, ranked #27.

Advent International first reported a position in RPID in Q3 2021 and has held it in 19 quarters since. The position peaked at $10.7M in Q3 2021. 46 funds tracked by Wall St. Rank hold RPID as of Q1 2026.

  • Advent International held 552,377 shares of Rapid Micro Biosystems worth $1.25M as of Q1 2026.
  • Advent International sold 25,400 Rapid Micro Biosystems shares in Q1 2026, an estimated $93K.
  • Rapid Micro Biosystems made up 0.03% of Advent International's portfolio in Q1 2026, its #27 holding.
  • Advent International first reported a position in Rapid Micro Biosystems in Q3 2021 and has held it in 19 quarters since.
  • Advent International's Rapid Micro Biosystems position peaked at $10.7M in Q3 2021.
  • 46 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2026.

Based on Advent International's 13F filing for Q1 2026, filed 15 May 2026.